Samsung, Celltrion lead biosimilar market in Europe, US

Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosim...

MSCI Korea Index adds Alteogen, Enchem, HD Hyundai Electric

South Korea's Alteogen Inc., Enchem Co., and HD Hyundai Electric Co. will be added to the Morgan Stanley Capital International (MSCI) Korea Index.MS...

HD Hyundai Electric likely to join MSCI Korea: Samsung Securities

HD Hyundai Electric Co., Alteogen Inc. and Enchem Co. are expected to be invited to join Morgan Stanley Capital International’s Korea Index wh...

Chong Kun Dang rallies on $1.3 bn deal with Novartis

Chong Kun Dang Pharmaceutical Corp.'s shares zoomed more than 25% on Monday on news that the South Korean medicine developer has signed its biggest-...

Samsung Bioepis to cooperate with Swiss firm Sandoz

Samsung Bioepis Co., a biopharmaceutical research and development unit under South Korea's Samsung Group, announced on Monday that it signed a partn...

Novartis $391 mn deal powers Samsung Biologics backlogs to record high

Samsung Biologics Co., the world’s top contract manufacturing organization by capacity, inked a $391 million contract from Novartis, nearly fi...

Smart transportation solution provider Alt-A enlists pre-Series A funding

Alt-A, which provides a transportation system specialized in last-mile roads, said Monday that it has received pre-series A funding from Shinh...

S.Korea's Alteogen signs $145 million tech export deal with Swiss company

South Korea's bio company Alteogen Inc. on Friday said it signed its fourth technology export contract since its 2018 development of the human recom...

Samsung Biologics signs $81 mn CMO deal with Novartis

South Korea’s Samsung Biologics Co. has inked an $81 million contract manufacturing deal with Novartis, the world’s fifth-largest pharma...

Shinsegae enters alternative meat market with own brand

South Korea’s retail conglomerate Shinsegae Group’s food affiliate Shinsegae Food Inc. has entered the fast-growing alternative meat mar...

Korean brokerage firm to buy Novartis campus in Paris for $454 mn: report

Korea Investment & Securities Co. Ltd. is set to buy an office building of Swiss pharmaceutical company Novartis under construction in Paris for 5...